Share Price and Basic Stock Data
Last Updated: October 16, 2025, 7:36 pm
| PEG Ratio | 0.20 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
HCP Plastene Bulkpack Ltd operates in the packaging and containers industry, with a current market capitalization of ₹177 Cr. The company’s sales have shown significant growth over recent years, with reported sales of ₹351 Cr for the fiscal year ending March 2023, rising to ₹463 Cr for the fiscal year ending March 2025. This upward trend is also reflected in the trailing twelve months (TTM) sales, which stood at ₹484 Cr. However, a noticeable decline in sales was recorded in FY 2024, where it dipped to ₹295 Cr, indicating potential operational challenges or market dynamics affecting the company’s performance. The quarterly sales figures also reveal fluctuations, with the most recent quarter (Jun 2024) reporting sales of ₹104.70 Cr, suggesting a recovery phase. The company’s ability to navigate these fluctuations will be crucial for its future performance in a competitive marketplace.
Profitability and Efficiency Metrics
HCP Plastene’s profitability metrics display a mixed performance trajectory. The Operating Profit Margin (OPM) stood at 7.28%, reflecting a modest capacity to convert sales into profit. Over the last fiscal years, the OPM has fluctuated, with a low of 2.32% in Jun 2023 and a recovery to 10.57% by Mar 2025. The net profit for FY 2025 is reported at ₹13 Cr, with an Earnings Per Share (EPS) of ₹12.51, indicating a significant recovery from previous losses. The Interest Coverage Ratio (ICR) of 2.73x suggests that the company is managing its interest obligations adequately, though it remains a point of scrutiny given the rising borrowings, which stood at ₹190 Cr. The Cash Conversion Cycle (CCC) has increased to 133 days, indicating potential inefficiencies in working capital management, which may impact liquidity if not addressed promptly.
Balance Sheet Strength and Financial Ratios
The balance sheet of HCP Plastene reveals a leverage situation that requires careful monitoring. As of March 2025, total borrowings reached ₹190 Cr against reserves of ₹49 Cr, suggesting a high reliance on debt financing. The Debt to Equity ratio stood at 3.19x, indicating a significant burden of debt relative to equity. Despite this, the company has shown improvements in Return on Capital Employed (ROCE), which rose to 13% in FY 2025, indicating better utilization of capital. The current ratio of 1.06x implies a reasonably strong liquidity position, although the quick ratio of 0.71x suggests some vulnerability in meeting short-term obligations. Overall, while the balance sheet shows signs of stress due to high debt levels, the company’s ability to generate profits from its capital investments is an encouraging sign for stakeholders.
Shareholding Pattern and Investor Confidence
The shareholding structure of HCP Plastene reflects a strong promoter commitment, with promoters holding 75% of the equity as of Mar 2025. This stable ownership structure may enhance investor confidence, particularly given that institutional investors (FIIs) hold a mere 0.07% stake, while domestic institutional investors (DIIs) account for 4.80%. The public shareholding has remained relatively stable at 20.13%, with a total of 5,147 shareholders reported. The reduction in promoter holding from 89% in previous quarters to 75% may raise concerns about insider selling, yet it also indicates a potential shift towards increasing public participation. The stability in shareholder numbers, despite some fluctuations, suggests a resilient investor interest in the company’s long-term prospects.
Outlook, Risks, and Final Insight
If margins sustain their upward trajectory and the company successfully addresses its cash conversion cycle inefficiencies, HCP Plastene could see enhanced profitability moving forward. However, the reliance on debt financing poses a risk if market conditions worsen or operational challenges persist. Additionally, fluctuations in quarterly sales may indicate broader market volatility or competitive pressures that the company needs to navigate effectively. If the company can leverage its strong promoter backing to stabilize operations and improve efficiency, it may position itself favorably within the packaging sector. Nonetheless, attention to liquidity management and operational efficiency will be crucial as it seeks to capitalize on its growth potential in an evolving market landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of HCP Plastene Bulkpack Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HCP Plastene Bulkpack Ltd | 178 Cr. | 167 | 216/88.8 | 14.8 | 55.8 | 0.00 % | 13.2 % | 17.7 % | 10.0 |
| Time Technoplast Ltd | 9,998 Cr. | 220 | 257/153 | 24.8 | 63.7 | 0.57 % | 17.4 % | 14.2 % | 1.00 |
| Huhtamaki India Ltd | 1,938 Cr. | 257 | 403/170 | 19.6 | 163 | 0.78 % | 7.14 % | 5.15 % | 2.00 |
| Flexituff Ventures International Ltd | 67.4 Cr. | 20.5 | 74.3/17.3 | 4.48 | 0.00 % | 8.07 % | % | 10.0 | |
| Industry Average | 4,038.00 Cr | 166.13 | 19.73 | 71.75 | 0.34% | 11.45% | 12.35% | 5.75 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 111.04 | 93.80 | 69.46 | 77.22 | 59.37 | 78.87 | 79.68 | 76.63 | 104.70 | 117.08 | 119.37 | 122.28 | 125.75 |
| Expenses | 106.05 | 89.70 | 66.00 | 74.11 | 57.99 | 74.03 | 74.69 | 71.15 | 98.11 | 109.57 | 111.18 | 109.36 | 116.59 |
| Operating Profit | 4.99 | 4.10 | 3.46 | 3.11 | 1.38 | 4.84 | 4.99 | 5.48 | 6.59 | 7.51 | 8.19 | 12.92 | 9.16 |
| OPM % | 4.49% | 4.37% | 4.98% | 4.03% | 2.32% | 6.14% | 6.26% | 7.15% | 6.29% | 6.41% | 6.86% | 10.57% | 7.28% |
| Other Income | 1.86 | 0.10 | 0.02 | 0.32 | 0.25 | 0.89 | 0.20 | 1.22 | 1.30 | 0.57 | 0.93 | 1.88 | 6.51 |
| Interest | 1.90 | 2.06 | 2.32 | 3.10 | 2.50 | 2.72 | 3.07 | 3.45 | 3.33 | 3.43 | 3.97 | 3.89 | 4.16 |
| Depreciation | 1.77 | 1.82 | 1.95 | 1.84 | 1.80 | 1.89 | 1.81 | 1.80 | 1.71 | 1.70 | 2.06 | 1.82 | 1.82 |
| Profit before tax | 3.18 | 0.32 | -0.79 | -1.51 | -2.67 | 1.12 | 0.31 | 1.45 | 2.85 | 2.95 | 3.09 | 9.09 | 9.69 |
| Tax % | 33.02% | 56.25% | -32.91% | -37.09% | -19.85% | 14.29% | 6.45% | 16.55% | 26.32% | 26.44% | 28.80% | -15.95% | 26.42% |
| Net Profit | 2.13 | 0.12 | -0.55 | -0.95 | -2.14 | 0.96 | 0.28 | 1.21 | 2.10 | 2.18 | 2.20 | 10.54 | 7.13 |
| EPS in Rs | 0.37 | -1.00 | -0.23 | -1.22 | -1.41 | 0.21 | -0.42 | 0.52 | 1.36 | 1.41 | 1.41 | 4.72 | 3.76 |
Last Updated: August 19, 2025, 1:55 pm
Below is a detailed analysis of the quarterly data for HCP Plastene Bulkpack Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 125.75 Cr.. The value appears strong and on an upward trend. It has increased from 122.28 Cr. (Mar 2025) to 125.75 Cr., marking an increase of 3.47 Cr..
- For Expenses, as of Jun 2025, the value is 116.59 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 109.36 Cr. (Mar 2025) to 116.59 Cr., marking an increase of 7.23 Cr..
- For Operating Profit, as of Jun 2025, the value is 9.16 Cr.. The value appears to be declining and may need further review. It has decreased from 12.92 Cr. (Mar 2025) to 9.16 Cr., marking a decrease of 3.76 Cr..
- For OPM %, as of Jun 2025, the value is 7.28%. The value appears to be declining and may need further review. It has decreased from 10.57% (Mar 2025) to 7.28%, marking a decrease of 3.29%.
- For Other Income, as of Jun 2025, the value is 6.51 Cr.. The value appears strong and on an upward trend. It has increased from 1.88 Cr. (Mar 2025) to 6.51 Cr., marking an increase of 4.63 Cr..
- For Interest, as of Jun 2025, the value is 4.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.89 Cr. (Mar 2025) to 4.16 Cr., marking an increase of 0.27 Cr..
- For Depreciation, as of Jun 2025, the value is 1.82 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.82 Cr..
- For Profit before tax, as of Jun 2025, the value is 9.69 Cr.. The value appears strong and on an upward trend. It has increased from 9.09 Cr. (Mar 2025) to 9.69 Cr., marking an increase of 0.60 Cr..
- For Tax %, as of Jun 2025, the value is 26.42%. The value appears to be increasing, which may not be favorable. It has increased from -15.95% (Mar 2025) to 26.42%, marking an increase of 42.37%.
- For Net Profit, as of Jun 2025, the value is 7.13 Cr.. The value appears to be declining and may need further review. It has decreased from 10.54 Cr. (Mar 2025) to 7.13 Cr., marking a decrease of 3.41 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.76. The value appears to be declining and may need further review. It has decreased from 4.72 (Mar 2025) to 3.76, marking a decrease of 0.96.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 12:57 pm
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Sales | 16 | 112 | 351 | 295 | 463 | 484 |
| Expenses | 19 | 106 | 334 | 278 | 428 | 447 |
| Operating Profit | -3 | 6 | 18 | 17 | 35 | 38 |
| OPM % | -20% | 5% | 5% | 6% | 8% | 8% |
| Other Income | 53 | 1 | 1 | 3 | 5 | 10 |
| Interest | 1 | 4 | 10 | 12 | 15 | 15 |
| Depreciation | 5 | 5 | 7 | 7 | 7 | 7 |
| Profit before tax | 44 | -3 | 1 | 0 | 18 | 25 |
| Tax % | -46% | -22% | 36% | -55% | 26% | |
| Net Profit | 64 | -2 | 1 | 0 | 13 | 22 |
| EPS in Rs | 38.79 | -2.86 | -2.07 | -1.11 | 9.02 | 11.30 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|
| YoY Net Profit Growth (%) | -103.12% | 150.00% | -100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 253.12% | -250.00% |
HCP Plastene Bulkpack Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 3 years from 2021-2022 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 60% |
| TTM: | 43% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 73% |
| TTM: | 577% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 110% |
| 3 Years: | -28% |
| 1 Year: | 2% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 4% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 3:41 pm
Balance Sheet
Last Updated: July 25, 2025, 1:07 pm
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 11 | 11 | 11 |
| Reserves | 16 | 15 | 39 | 39 | 49 |
| Borrowings | 38 | 109 | 123 | 158 | 190 |
| Other Liabilities | 8 | 39 | 27 | 25 | 26 |
| Total Liabilities | 72 | 174 | 200 | 233 | 276 |
| Fixed Assets | 27 | 79 | 84 | 77 | 73 |
| CWIP | 0 | 0 | 1 | 4 | 0 |
| Investments | 0 | 0 | 1 | 1 | 1 |
| Other Assets | 45 | 94 | 115 | 152 | 203 |
| Total Assets | 72 | 174 | 200 | 233 | 276 |
Below is a detailed analysis of the balance sheet data for HCP Plastene Bulkpack Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
- For Reserves, as of Mar 2025, the value is 49.00 Cr.. The value appears strong and on an upward trend. It has increased from 39.00 Cr. (Mar 2024) to 49.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Mar 2025, the value is 190.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 158.00 Cr. (Mar 2024) to 190.00 Cr., marking an increase of 32.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 26.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25.00 Cr. (Mar 2024) to 26.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 276.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 233.00 Cr. (Mar 2024) to 276.00 Cr., marking an increase of 43.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 73.00 Cr.. The value appears to be declining and may need further review. It has decreased from 77.00 Cr. (Mar 2024) to 73.00 Cr., marking a decrease of 4.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 4.00 Cr..
- For Investments, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
- For Other Assets, as of Mar 2025, the value is 203.00 Cr.. The value appears strong and on an upward trend. It has increased from 152.00 Cr. (Mar 2024) to 203.00 Cr., marking an increase of 51.00 Cr..
- For Total Assets, as of Mar 2025, the value is 276.00 Cr.. The value appears strong and on an upward trend. It has increased from 233.00 Cr. (Mar 2024) to 276.00 Cr., marking an increase of 43.00 Cr..
However, the Borrowings (190.00 Cr.) are higher than the Reserves (49.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Free Cash Flow | -41.00 | -103.00 | -105.00 | -141.00 | -155.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debtor Days | 76 | 87 | 29 | 70 | 71 |
| Inventory Days | 225 | 115 | 38 | 65 | 61 |
| Days Payable | 245 | 94 | 10 | 7 | -1 |
| Cash Conversion Cycle | 56 | 108 | 57 | 129 | 133 |
| Working Capital Days | 85 | 43 | 28 | -5 | 7 |
| ROCE % | 1% | 6% | 6% | 13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 12.51 | 0.37 | 1.06 | -2.39 | 65.80 |
| Diluted EPS (Rs.) | 9.02 | 0.37 | 1.01 | -2.39 | 65.80 |
| Cash EPS (Rs.) | 19.34 | 7.12 | 7.63 | 2.73 | 67.17 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 55.81 | 61.23 | 60.39 | 36.08 | 25.70 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 55.81 | 61.23 | 60.39 | 36.08 | 25.70 |
| Revenue From Operations / Share (Rs.) | 434.14 | 275.94 | 329.30 | 109.63 | 15.51 |
| PBDIT / Share (Rs.) | 37.39 | 18.01 | 16.65 | 5.84 | -3.42 |
| PBIT / Share (Rs.) | 30.56 | 11.18 | 9.73 | 0.72 | -8.43 |
| PBT / Share (Rs.) | 16.86 | 0.18 | 1.11 | -3.09 | 42.53 |
| Net Profit / Share (Rs.) | 12.51 | 0.28 | 0.71 | -2.39 | 62.17 |
| NP After MI And SOA / Share (Rs.) | 9.02 | -1.11 | -2.07 | -2.39 | 62.17 |
| PBDIT Margin (%) | 8.61 | 6.52 | 5.05 | 5.33 | -22.05 |
| PBIT Margin (%) | 7.03 | 4.04 | 2.95 | 0.65 | -54.33 |
| PBT Margin (%) | 3.88 | 0.06 | 0.33 | -2.81 | 274.26 |
| Net Profit Margin (%) | 2.88 | 0.10 | 0.21 | -2.18 | 400.86 |
| NP After MI And SOA Margin (%) | 2.07 | -0.40 | -0.62 | -2.18 | 400.86 |
| Return on Networth / Equity (%) | 16.15 | -2.39 | -4.41 | -9.54 | 241.85 |
| Return on Capital Employeed (%) | 28.33 | 10.45 | 6.92 | 0.59 | -13.40 |
| Return On Assets (%) | 3.48 | -0.50 | -1.10 | -1.41 | 87.93 |
| Long Term Debt / Equity (X) | 0.54 | 0.96 | 1.63 | 3.42 | 1.44 |
| Total Debt / Equity (X) | 3.19 | 3.19 | 2.44 | 4.24 | 1.44 |
| Asset Turnover Ratio (%) | 1.82 | 1.36 | 1.88 | 0.64 | 0.00 |
| Current Ratio (X) | 1.06 | 0.97 | 1.56 | 1.24 | 1.50 |
| Quick Ratio (X) | 0.71 | 0.67 | 1.02 | 0.72 | 0.68 |
| Inventory Turnover Ratio (X) | 7.62 | 6.74 | 6.67 | 5.49 | 0.00 |
| Interest Coverage Ratio (X) | 2.73 | 1.64 | 1.89 | 1.53 | -2.76 |
| Interest Coverage Ratio (Post Tax) (X) | 1.91 | 1.03 | 1.06 | 0.37 | 9.05 |
| Enterprise Value (Cr.) | 319.31 | 372.53 | 338.47 | 713.16 | 47.08 |
| EV / Net Operating Revenue (X) | 0.68 | 1.26 | 0.96 | 6.36 | 2.97 |
| EV / EBITDA (X) | 8.00 | 19.38 | 19.05 | 119.23 | -13.45 |
| MarketCap / Net Operating Revenue (X) | 0.23 | 0.67 | 0.57 | 5.29 | 0.58 |
| Price / BV (X) | 1.85 | 4.03 | 4.05 | 23.13 | 0.35 |
| Price / Net Operating Revenue (X) | 0.23 | 0.67 | 0.57 | 5.29 | 0.58 |
| EarningsYield | 0.08 | -0.01 | -0.01 | 0.00 | 6.83 |
After reviewing the key financial ratios for HCP Plastene Bulkpack Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.51. This value is within the healthy range. It has increased from 0.37 (Mar 24) to 12.51, marking an increase of 12.14.
- For Diluted EPS (Rs.), as of Mar 25, the value is 9.02. This value is within the healthy range. It has increased from 0.37 (Mar 24) to 9.02, marking an increase of 8.65.
- For Cash EPS (Rs.), as of Mar 25, the value is 19.34. This value is within the healthy range. It has increased from 7.12 (Mar 24) to 19.34, marking an increase of 12.22.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.81. It has decreased from 61.23 (Mar 24) to 55.81, marking a decrease of 5.42.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.81. It has decreased from 61.23 (Mar 24) to 55.81, marking a decrease of 5.42.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 434.14. It has increased from 275.94 (Mar 24) to 434.14, marking an increase of 158.20.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 37.39. This value is within the healthy range. It has increased from 18.01 (Mar 24) to 37.39, marking an increase of 19.38.
- For PBIT / Share (Rs.), as of Mar 25, the value is 30.56. This value is within the healthy range. It has increased from 11.18 (Mar 24) to 30.56, marking an increase of 19.38.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.86. This value is within the healthy range. It has increased from 0.18 (Mar 24) to 16.86, marking an increase of 16.68.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.51. This value is within the healthy range. It has increased from 0.28 (Mar 24) to 12.51, marking an increase of 12.23.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 9.02. This value is within the healthy range. It has increased from -1.11 (Mar 24) to 9.02, marking an increase of 10.13.
- For PBDIT Margin (%), as of Mar 25, the value is 8.61. This value is below the healthy minimum of 10. It has increased from 6.52 (Mar 24) to 8.61, marking an increase of 2.09.
- For PBIT Margin (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 10. It has increased from 4.04 (Mar 24) to 7.03, marking an increase of 2.99.
- For PBT Margin (%), as of Mar 25, the value is 3.88. This value is below the healthy minimum of 10. It has increased from 0.06 (Mar 24) to 3.88, marking an increase of 3.82.
- For Net Profit Margin (%), as of Mar 25, the value is 2.88. This value is below the healthy minimum of 5. It has increased from 0.10 (Mar 24) to 2.88, marking an increase of 2.78.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.07. This value is below the healthy minimum of 8. It has increased from -0.40 (Mar 24) to 2.07, marking an increase of 2.47.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.15. This value is within the healthy range. It has increased from -2.39 (Mar 24) to 16.15, marking an increase of 18.54.
- For Return on Capital Employeed (%), as of Mar 25, the value is 28.33. This value is within the healthy range. It has increased from 10.45 (Mar 24) to 28.33, marking an increase of 17.88.
- For Return On Assets (%), as of Mar 25, the value is 3.48. This value is below the healthy minimum of 5. It has increased from -0.50 (Mar 24) to 3.48, marking an increase of 3.98.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. It has decreased from 0.96 (Mar 24) to 0.54, marking a decrease of 0.42.
- For Total Debt / Equity (X), as of Mar 25, the value is 3.19. This value exceeds the healthy maximum of 1. There is no change compared to the previous period (Mar 24) which recorded 3.19.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.82. It has increased from 1.36 (Mar 24) to 1.82, marking an increase of 0.46.
- For Current Ratio (X), as of Mar 25, the value is 1.06. This value is below the healthy minimum of 1.5. It has increased from 0.97 (Mar 24) to 1.06, marking an increase of 0.09.
- For Quick Ratio (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.67 (Mar 24) to 0.71, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.62. This value is within the healthy range. It has increased from 6.74 (Mar 24) to 7.62, marking an increase of 0.88.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.73. This value is below the healthy minimum of 3. It has increased from 1.64 (Mar 24) to 2.73, marking an increase of 1.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 3. It has increased from 1.03 (Mar 24) to 1.91, marking an increase of 0.88.
- For Enterprise Value (Cr.), as of Mar 25, the value is 319.31. It has decreased from 372.53 (Mar 24) to 319.31, marking a decrease of 53.22.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has decreased from 1.26 (Mar 24) to 0.68, marking a decrease of 0.58.
- For EV / EBITDA (X), as of Mar 25, the value is 8.00. This value is within the healthy range. It has decreased from 19.38 (Mar 24) to 8.00, marking a decrease of 11.38.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.67 (Mar 24) to 0.23, marking a decrease of 0.44.
- For Price / BV (X), as of Mar 25, the value is 1.85. This value is within the healthy range. It has decreased from 4.03 (Mar 24) to 1.85, marking a decrease of 2.18.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.67 (Mar 24) to 0.23, marking a decrease of 0.44.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.08, marking an increase of 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in HCP Plastene Bulkpack Ltd:
- Net Profit Margin: 2.88%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 28.33% (Industry Average ROCE: 11.45%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.15% (Industry Average ROE: 12.35%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.91
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.71
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.8 (Industry average Stock P/E: 19.73)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.19
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.88%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Packaging & Containers | H B Jirawala House, 13 Nav Bharat Society, Ahmedabad Gujarat 380013 | cs@gopalapolyplast.com http://www.gopalapolyplast.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anil Shyamsunder Goyal | Chairman |
| Mr. Prakash Hiralal Parekh | Managing Director |
| Mr. Sandeep Motilal Shah | Ind. Non-Executive Director |
| Ms. Meenu Maheshwari | Ind. Non-Executive Director |
| Mr. Ashutosh Maheshwari | Ind. Non-Executive Director |
| Dr. Ranjeet Mal kastia | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of HCP Plastene Bulkpack Ltd?
HCP Plastene Bulkpack Ltd's intrinsic value (as of 16 October 2025) is 119.28 which is 28.57% lower the current market price of 167.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 178 Cr. market cap, FY2025-2026 high/low of 216/88.8, reserves of ₹49 Cr, and liabilities of 276 Cr.
What is the Market Cap of HCP Plastene Bulkpack Ltd?
The Market Cap of HCP Plastene Bulkpack Ltd is 178 Cr..
What is the current Stock Price of HCP Plastene Bulkpack Ltd as on 16 October 2025?
The current stock price of HCP Plastene Bulkpack Ltd as on 16 October 2025 is 167.
What is the High / Low of HCP Plastene Bulkpack Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of HCP Plastene Bulkpack Ltd stocks is 216/88.8.
What is the Stock P/E of HCP Plastene Bulkpack Ltd?
The Stock P/E of HCP Plastene Bulkpack Ltd is 14.8.
What is the Book Value of HCP Plastene Bulkpack Ltd?
The Book Value of HCP Plastene Bulkpack Ltd is 55.8.
What is the Dividend Yield of HCP Plastene Bulkpack Ltd?
The Dividend Yield of HCP Plastene Bulkpack Ltd is 0.00 %.
What is the ROCE of HCP Plastene Bulkpack Ltd?
The ROCE of HCP Plastene Bulkpack Ltd is 13.2 %.
What is the ROE of HCP Plastene Bulkpack Ltd?
The ROE of HCP Plastene Bulkpack Ltd is 17.7 %.
What is the Face Value of HCP Plastene Bulkpack Ltd?
The Face Value of HCP Plastene Bulkpack Ltd is 10.0.